NOX Peptides, a Canadian peptide company, has made its full lab documentation publicly accessible for every compound in its catalog. Researchers and performance-focused individuals who want to buy peptides in Canada can now review purity percentages, average mass figures, and endotoxin readings for each batch before placing an order. The reports are listed under the Lab Results section of the NOX Peptides website.
This move comes at a time when the peptides canada market has seen growing demand but inconsistent standards around product verification. Many suppliers operating in this space provide limited documentation, and what is available is not always tied to a specific batch or independently verified. NOX Peptides has taken a different position by publishing batch-specific data that customers can cross-reference with their own orders.
The decision to make this information public was not a recent one. It has been part of how the company operates since it began producing compounds. Every batch that comes out of the NOX Peptides facility goes through a defined set of checks before it is approved for release. Those checks cover compound identity, purity confirmation, and endotoxin screening. A batch that does not meet the required threshold across all three areas does not move forward, regardless of timeline or demand.
For compounds like bpc157 and tb500, where researchers are working with material that directly influences their study outcomes, knowing the exact purity of what they are using matters. bpc157, which has been studied in tissue repair and joint recovery research, is carried by NOX Peptides at a documented average purity of 99.77%. TB500, which comes up frequently in research around cell migration and healing response, is available alongside a full batch report that covers the same data points.
The catalog also includes compounds used in metabolic and weight loss research. Retatrutide, a triple-receptor compound originally developed by Eli Lilly, has drawn attention from researchers exploring weight loss canada applications because of how it engages GLP-1, GIP, and glucagon pathways simultaneously. NOX Peptides carries retatrutide in both 5mg and 30mg formats. Purity for the 5mg batch has been confirmed at 99.814%, and the 30mg batch has come back at 99.93% across testing.
Other compounds in the catalog include MOTS-C for metabolism research, CJC-1295 and Ipamorelin for growth hormone signaling studies, DSIP for sleep research, and GHK-CU for work in the anti-aging and tissue repair space. Each of these carries the same batch documentation standard that applies across the full NOX Peptides catalog.
Production at NOX Peptides is handled through yeast-based and precision cell culture systems. This gives the company control over how peptides are formed at the molecular level and how they are separated during harvesting. The goal at the harvesting stage is to keep the finished compound clean by minimizing the carry-over of unwanted proteins or cellular material. This keeps the starting quality high before the batch even reaches the testing phase.
The endotoxin testing component is worth noting separately. Lipopolysaccharide contamination, commonly referred to as LPS, is a concern in peptide production because it can interfere with research outcomes if present at elevated levels. NOX Peptides screens every batch for endotoxin presence and only releases material that falls within strict thresholds. This is one area where many suppliers in the peptides Canada space do not provide public data, and NOX Peptides has made it a standard part of its published reports.
Researchers who work with these compounds on an ongoing basis can access volume pricing across most catalog items. New customers are also eligible for a first-order discount at checkout. The company’s support team is reachable for questions related to specific compounds, batch reports, or order details.
About NOX Peptides
NOX Peptides is a Canadian company that synthesizes and distributes research-grade performance compounds for researchers and individuals operating within structured, protocol-based environments. All products are produced domestically using yeast-based cell culture systems and verified through analytical identity testing, purity confirmation, and endotoxin screening before release. Batch-level lab reports covering purity, mass, and endotoxin data are published openly for every product in the catalog.
Media Contact
Company: NOX
Contact Person: Peter Tran
Email: info@noxpeptides.ca
City & Country: 2242 Kingsway, Vancouver, BC V5N 5X6
Website: noxpeptides.ca
